CASP Module 26: Feasibility, Strategy & Pro Forma Development
CASP Owner / Founder Track

Module 26: Feasibility, Strategy & Pro Forma Development

Laying the Foundation: Transforming Your Specialty Pharmacy Vision into a Viable Business Blueprint.

Before the First Script: Architecting Your Specialty Pharmacy Success

The leap from practicing pharmacist to specialty pharmacy founder is exhilarating, yet fraught with potential pitfalls. Your clinical expertise is invaluable, but it’s only one pillar supporting a successful enterprise. This foundational module shifts your focus from patient care pathways to business viability pathways. Before investing significant capital, time, and reputation, a rigorous assessment of feasibility and a meticulously crafted strategy are paramount.

Many well-intentioned pharmacy ventures fail not due to clinical incompetence, but due to inadequate planning – underestimating competition, misjudging capital needs, failing to define a clear value proposition, or lacking a realistic financial forecast. This module is your intensive workshop in due diligence. We will dissect the market, force difficult strategic choices about your service scope, and translate your operational assumptions into the language investors and lenders understand: the pro forma financial statement.

Think of this module as designing the architectural blueprints before breaking ground. We will scrutinize the landscape, define the structure, calculate the materials needed, and project the final costs and potential returns. Mastering this stage is the single most important step in de-risking your entrepreneurial journey and setting the stage for a sustainable, scalable specialty pharmacy business tailored to the unique demands of this complex market.

Your Strategic Planning Toolkit

This module provides the essential frameworks and analytical tools to rigorously evaluate your specialty pharmacy concept and build a robust business plan.

26.1 Market Opportunity & Competitive Landscape Analysis

Identifying your niche: Deep dive into analyzing patient populations, prescriber trends, existing specialty pharmacy competitors (local, regional, national PBM-owned), payer mix, and unmet needs within specific therapeutic areas relevant to specialty pharmacy.

26.2 Defining Service Scope: Limited vs. Broad Specialty

Strategic focus vs. diversification: Evaluating the operational, clinical, and financial trade-offs between launching with a narrow therapeutic focus (e.g., oncology only) versus a broader range of specialty conditions, considering accreditation requirements and payer network access implications.

26.3 Start-Up Capital, Inventory, and Cash-Flow Planning

Funding your launch: Estimating capital expenditures (facility, technology, licensing), initial high-cost inventory investment (consignment vs. buy-and-bill), staffing costs, and projecting month-by-month cash flow needs until achieving profitability in the unique reimbursement cycle of specialty pharmacy.

26.4 Financial Pro Forma: Revenue Streams and Expense Forecast

Building your financial model: Projecting realistic revenue based on payer contracts, script volume, and reimbursement rates (including DIR/GER fees), forecasting cost of goods sold (COGS), operating expenses (OpEx), and developing key financial statements (P&L, Balance Sheet, Cash Flow) specific to a specialty pharmacy startup.

26.5 Phased Rollout and Scalability Model

Planning for growth: Designing a staged launch strategy (e.g., specific payers, therapeutic areas, or geographic regions first), defining key milestones for expansion, and building operational scalability into your initial design for staffing, technology, and facility footprint specific to specialty pharmacy volume increases.